2024

1. Cho E, Mun SJ, Kim HK,  Ham YS, Gill WJ, Yang CS*. Colon-targeted S100A8/A9-specific peptide systems ameliorate colitis and colitis-

    associated colorectal cancer in mouse models. Acta Pharmacol Sin. 2024 Mar;45(3):581-593. 

2. Yoon C, Ham YS, Gil WJ, Yang CS*. Exploring the potential of Toxoplasma gondii as a drug development and delivery system.

    Exp Mol Med. 2024 Feb;56(2):289-300.

3. Kim S, Kim HK, Park EJ, Park JO, Shin M, Kim D, Yang CS*, Kong H*, Kim JW* (*contributed equally). All-in-one tissue adhesive hydrogels for

    topical wound caring. Chem. Eng. J. 2024 Mar 19;487:150547.

4. Hong D, Kim HK, Yang W, Yoon C, Kim M, Yang CS*, Yoon S* (*contributed equally). Integrative analysis of single-cell RNA-seq and gut

    microbiome metabarcoding data elucidates macrophage dysfunction in mice with DSS-induced ulcerative colitis.

    Commun Biol. 2024 Jun 15;7(1):731.

5. Mun SJ, Cho E, Kim HK, Gill WJ, Yang CS*. Enhancing acute inflammatory and sepsis treatment: superiority of membrane receptor

    blockade. Front. Immunol. 2024 Jul 16:15:1424768.

6. Yoon C, Kim HK, Ham YS, Yang CS*. Effect of Morning Care Products Administration on the Ethanol-induced Hangover in Mice.

    Food Eng. Prog. 2024 Aug 30;28(3):188-197.

7. Yoon C, Mun SJ, Cho E, Kim HK, Gill WJ, Ham YS, Yuk JM, Yang CS*. Toxoplasma gondii macrophage migration inhibitory factor shows

    anti-Mycobacterium tuberculosis potential via AZIN1/STAT1 interaction. Sci. Adv.​ 2024 Oct 25;10(43):eadq0101.

8. Choi C, Yim D, Kim HK, Jeon SJ, Hwang IJ, Kim H, So Y, Lee S, Choi Y, Lee H, Yang CS*, Kim JH* (*contributed equally). ​Crystalline Carbon

    Antioxidase Mimics Enhancing Innate Anti-inflammatory Immunity for the Treatment of Rheumatoid Arthritis. Chem. Eng. J. 2024 Nov 14;500:157629.

9. Mun SJ, Cho E, Kim HK, Ham YS, Gill WJ, Yang CS*. Dual alarmin-receptor-specific targeting peptide systems for treatment of sepsis. 

    Acta Pharm Sin B. 2024 in press

10. So Y, Yim D, Kim HK, Lee S, Lee H, Yu Y, Choi C, Choi Y, Yang CS*, Kim JH* (*contributed equally). Functional Nanosheet Immunoswitches

    Reprogramming Macrophages for Treatment of Colorectal Cancer and Sepsis. Revision in ACS Nano.

11. Jeon S, Yun J, Heo BE, Nguyen T, Ash A, Lee H, Moon C, Yang CS*, Jang J*(*contributed equally). Identification of a drug candidate against            Mycobacterium avium using Pandemic Response Box. Review in Journal of Microbiology.

12. Cho YJ, Shin SY, Yang J, Kim HK, Rintarhat P, Park M, Lagree K, Underhill DM, Choi CH, Yang CS*, Jung WH* (*contributed equally). Live 

    Malassezia strains isolated from the mucosa of patients with ulcerative colitis. Review in mBio.​​

13. Kim HK, Kim SJ, Gil WJ, Yang CS*. Clinical Translation of Phytochemicals: Addressing Key Therapeutic Barriers. Review in

​

14. T.gondii GRA2 - Lung Cancer

​15. Runx1 / Colon Cancer

16. NLRP3 / Colitis / Colon Cancer

17. cGAS/STING, Review

18. DATPT / NTM

19. MS / PKM2

20. Fusobacteria-NLRP3/ASC

21. Ag85 / Sepsis

​

Books

1. The Great Secret of Microbes 2 미생물의 은밀한 비밀 (ISBN: 979-11-5943-440-2, 범문에듀케이션, 2024), 양철수

​

2023

1. Lee Y, Kim S, Seo J, Park EJ, Park JO, Han YP, Yang CS*, Kim JW* (*contributed equally). Collagen-derived Peptide-Conjugated Smart     

    Polymeric Nanovehicles for Enhancing In Vitro Wound Healing. Biomater Sci. 2023 Jan 17;11(2):450-460.

2.  Kim JS, Kim HK, Lee J, Jang S, Cho E, Mun SJ, Yoon S, Yang CS*. Inhibition of CD82 improves colitis by increasing deubiquitination activities

     in NLRP3 by BRCC3. Cell Mol Immunol. 2023 Feb;20(2):189-200.

3. Lee J, Kim M, Kang K, Yang CS, Yoon S. Hierarchical cell-type identifier accurately distinguishes immune-cell subtypes enabling precise profiling

    of tissue microenvironment with single-cell RNA-sequencing. Brief Bioinform. 2023. Mar 19;24(2):bbad006. 

4. Kim H, Kim HK, Hong D, Kim M, Jang S, Yang CS, Yoon S. Identification of ulcerative colitis-specific immune cell signatures from public

    single-cell RNA-seq data. Genes Genomics. 2023. Jul;45(7):957-967.

5. Choi Y, Son W, Han Y, Chae J, Yang CS*, Choi J* (*contributed equally). Glycan-targeting nanoparticle for photodynamic immunotherapy of

    melanoma. Acta Pharm Sin B. 2023. May;13(5):1903-1918.

6. Cho E, Mun SJ, Jeon M, Kim HK, Baek H, Ham YS, Gill WJ, Kim JW, Yang CS*. Tumor-Targeted Liposomes with Platycodin D2 Promotes

    Apoptosis in Colorectal Cancer. Materials Today Bio. 2023 Jul 29;22:100745.

​

2022

1. Lee D, Lee Eb, Kim K, Cho E, Mun SJ, Son W, Jeon HI, Kim HK, Jeong YJ, Jang S, Lee Y, Min SJ, Yang CS*.

    Discovery of Mycobacterium  tuberculosis Rv3364c-derived small molecules as potential therapeutic agents

    to target SNX9 for sepsis. J. Med. Chem. 2022 Jan 13;65(1):386-408.

​

​

2. Kim JS, Kim HK, Cho E, Mun SJ, Jang S, Jang J, Yang CS*. PE_PGRS38 interaction with HAUSP downregulates antimycobacterial host

    defense via TRAF6. Front. Immunol. 2022 Apr 28;13:862628.

3. Lee J, Kim J, Heo I, Kim SJ, Lee HY, Jang S, Jang KS, Yang CS, Lee Y, Yoo WC, Min SJ. One-Pot Bifunctionalization of Silica Nanoparticles

    Conjugated with Bioorthogonal Linkers: Application in Dual-modal Imaging. Biomater Sci. 2022 Jun 28;10(13):3540-3546.

4. Mun SJ, Cho E, Kim JS, Yang CS*. Pathogen-derived peptides in Drug Targeting and its Therapeutic Approach.

    J Control Release. 2022 Sep 7;350:716-733.

5. Kim JS, Kim HK, Kim M, Jang S, Cho E, Mun SJ, Lee J, Hong D, Yoon S, Yang CS*. Colon-targeted eNAMPT-specific peptide systems for

    treatment of DSS-induced acute and chronic colitis in mouse. Antioxidants. 2022 Nov 30;11(12):2376.

6. Yoon C, Ham YS, Gil WJ, Yang CS*. The strategies of NLRP3 inflammasome to combat Toxoplasma gondii.

    Front Immunol. 2022 Oct 19;13:1002387

7. So Y, Yim D, Son W, Lee HJ, Lee S, Choi C, Yang CS*, Kim JH* (*contributed equally). Oxidative Stress-Suppressive WS2 Nanosheet

    Antipyrotics Enhancing Cellular Defense Mechanisms for the Treatment of Deep Burn Wounds. Applied Materials Today 2022, 29, 101591.

​

2021

1. Song Y, Jo S, Chung JY, Oh Y, Yoon S, Lee YL, Kim SS, Yang JH, Jang K, Yang CS, Kim TH, Kim YH. RNA interference-mediated suppression

     of TNF-α converting enzyme as an alternative anti-TNF-α therapy for rheumatoid arthritis. J Control Release. 2021 Feb 10;330:1300-1312.

2. Kang JY, Kim S, Kim J, Kang NG, Yang CS, Min SJ, Kim JW. Cell-penetrating peptide-conjugated lipid/polymer hybrid nanovesicles for       

    endoplasmic reticulum-targeting intracellular delivery. J Mater Chem B. 2021 Jan 21;9(2):464-470.

3. Kang TW, Hwang IJ, Lee S, Jeon SJ, Choi C, Han J, So Y, Son W, Kim H, Yang CS, Park JH, Lee H, Kim JH. Multivalent Nanosheet Antibody

    Mimics for Selective Microbial Recognition and Inactivation. Adv Mater. 2021 Apr 23:e2101376.

4. Kim JS, Cho E, Mun SJ, Kim S, Kim SY, Kim D, Son W, Jeon HI, Kim HK, Jeong YJ, Jang S, Kim H, Yang CS*. 

     Multi-functional MPT protein as a therapeutic agent against Mycobacterium tuberculosis. Biomedicines. 2021 May 13;9(5):545.

5. Lee J, Son W, Hong J, Song Y, Yang CS*, Kim YH* (*contributed equally). Down-regulation of TNF-α via Macrophage-targeted RNAi system for

    the treatment of acute inflammatory sepsis. J Control Release. 2021 Aug 10;336:344-353.

6. Lee S, Kang TW, Hwang IJ, Kim HI, Jeon SJ, Yim D, Choi C, Son W, Kim H, Yang CS, Lee H, Kim JH. Transition-Metal Dichalcogenide Artificial

    Antibodies with Multivalent Polymeric Recognition Phases for Rapid Detection and Inactivation of Pathogens.

    J Am Chem Soc. 2021 Sep 15;143(36):14635-14645.

7. Kim JS, Kim YR, Jang S, Wang SG, Cho E, Mun SJ, Jeon HI, Kim HK, Min SJ, Yang CS*. Mito-TIPTP increases mitochondrial function by

    repressing the Rubicon-p22phox interaction in colitis-induced mice. Antioxidants. 2021 Dec 6;10(12):1954.

​

Books

1. The Great Secret of Microbes 미생물의 위대한 비밀 (ISBN: 978-89-6154-342-2, 라이프사이언스, 2021), 양철수

2. Prime Archives in Immunology: 2nd Edition
    Book Chapter. Host-Directed Therapy in Tuberculosis: Targeting Host Metabolism
    ISBN : 978-93-90014-38-5

​

​

​